TNP-470 Suppresses the Tumorigenicity of HT1080 Fibrosarcoma Tumor Through the Inhibition of VEGF Secretion From the Tumor Cells

Angiogenesis inhibitors are a novel class of promising therapeutic agents for treating cancer. TNP-470, a systemic analogue of fumagillin, is an angiogenesis inhibitor capable of suppressing the tumorigenicity in several animal models even though the mechanisms of action have not been completely cla...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaya, Mitsunori, Wada, Takuro, Nagoya, Satoshi, Kawaguchi, Satoshi, Yamashita, Toshihiko, Yamamoto, Nobuyuki, Yoshimoto, Mitsunori, Okada, Futoshi, Ishii, Seiichi
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395463/
https://www.ncbi.nlm.nih.gov/pubmed/18521314
http://dx.doi.org/10.1080/13577140120099182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395463/
https://www.ncbi.nlm.nih.gov/pubmed/18521314
http://dx.doi.org/10.1080/13577140120099182

Ejemplares similares